Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
12.73
-0.63 (-4.72%)
Jan 28, 2026, 4:00 PM EST - Market closed
Wave Life Sciences Revenue
In the year 2024, Wave Life Sciences had annual revenue of $108.30M, down -4.42%. Wave Life Sciences had revenue of $7.61M in the quarter ending September 30, 2025, a decrease of -84.54%.
Revenue (ttm)
$108.30M
Revenue Growth
+630.39%
P/S Ratio
19.11
Revenue / Employee
$379,271
Employees
288
Market Cap
2.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 108.30M | -5.00M | -4.42% |
| Dec 31, 2023 | 113.31M | 109.66M | 3,005.10% |
| Dec 31, 2022 | 3.65M | -37.32M | -91.09% |
| Dec 31, 2021 | 40.96M | 24.98M | 156.30% |
| Dec 31, 2019 | 15.98M | 1.57M | 10.89% |
| Dec 31, 2018 | 14.41M | 10.52M | 270.25% |
| Dec 31, 2017 | 3.89M | 3.74M | 2,461.18% |
| Dec 31, 2015 | 152.00K | - | - |
| Dec 31, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Telix Pharmaceuticals | 664.23M |
| Ultragenyx Pharmaceutical | 630.60M |
| Travere Therapeutics | 435.83M |
| Galapagos NV | 336.64M |
| Ascentage Pharma Group International | 54.52M |
| Recursion Pharmaceuticals | 43.69M |
| Mesoblast | 17.20M |
| Dianthus Therapeutics | 3.08M |
WVE News
- 7 days ago - MoneyShow's Best Investment Ideas For 2026: Part 9 - Seeking Alpha
- 15 days ago - Wave Life Sciences Ltd. (WVE) Presents at 44th Annual J.P. - Seeking Alpha
- 16 days ago - Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio - GlobeNewsWire
- 23 days ago - Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Why Did Wave Life Sciences Surge 147%? - Forbes
- 7 weeks ago - Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - GlobeNewsWire
- 7 weeks ago - What's Going On With Wave Life Sciences Stock Tuesday? - Benzinga
- 7 weeks ago - Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - GlobeNewsWire